Related Experiment Videos

alpha 1-antitrypsin deficiency in Israeli children: a five-year survey

Israel Journal of Medical Sciences
|July 1, 1982
PubMed

Insights

Alpha 1-antitrypsin (AAT) deficiency is a rare cause of pediatric liver disease in Israel. A 5-year study found no cases of AAT deficiency among 300 pediatric patients, indicating its low prevalence in the region.

Area of Science:

  • Hepatology
  • Pediatrics
  • Genetics

Background:

  • Alpha 1-antitrypsin (AAT) deficiency is an inherited disorder that can lead to liver disease in children.
  • Understanding the prevalence of AAT deficiency is crucial for diagnosing and managing pediatric liver conditions.

Purpose of the Study:

  • To determine the significance of alpha 1-antitrypsin (AAT) deficiency as a cause of liver disease in pediatric patients in Israel.
  • To assess the prevalence of AAT deficiency within the Israeli pediatric population.

Main Methods:

  • A retrospective 5-year study was conducted.
  • Liver biopsies (n=51) were screened for AAT inclusion bodies using the immunoperoxidase technique.
  • Serum AAT concentrations were reviewed for 300 pediatric patients.

Main Results:

  • No cases of alpha 1-antitrypsin deficiency were detected in the studied pediatric population.
  • The immunoperoxidase staining of liver biopsies did not reveal AAT inclusion bodies.
  • Serum AAT concentration reviews did not identify any deficient cases.

Conclusions:

  • Alpha 1-antitrypsin deficiency appears to be rare as a cause of liver disease in children in Israel.
  • Further research may be warranted to confirm these findings in a broader population.
  • The low prevalence suggests other etiologies are more common for pediatric liver disease in this region.

Related Concept Videos